Novel therapeutic strategy for neurogenesis in the neurodegenerative disorders

Kohji Fukunaga; Norifumi Shioda; Motohiro Morioka; Feng Han

doi:10.1254/fpj.131.341

Novel therapeutic strategy for neurogenesis in the neurodegenerative disorders

Kohji Fukunaga, Norifumi Shioda, Motohiro Morioka, Feng Han

PHA - Life and Pharmaceutical Science

Research output: Contribution to journal › Review article

1 Citation (Scopus)

Original language	English
Pages (from-to)	341-346
Number of pages	6
Journal	Folia Pharmacologica Japonica
Volume	131
Issue number	5
DOIs	https://doi.org/10.1254/fpj.131.341
Publication status	Published - 2008 Jul 15

ASJC Scopus subject areas

Pharmacology

Access to Document

10.1254/fpj.131.341

Cite this

Fukunaga, K., Shioda, N., Morioka, M., & Han, F. (2008). Novel therapeutic strategy for neurogenesis in the neurodegenerative disorders. Folia Pharmacologica Japonica, 131(5), 341-346. https://doi.org/10.1254/fpj.131.341

@article{90922e58fc1146579f47299bd17ed6a5,

title = "Novel therapeutic strategy for neurogenesis in the neurodegenerative disorders",

author = "Kohji Fukunaga and Norifumi Shioda and Motohiro Morioka and Feng Han",

year = "2008",

month = jul,

day = "15",

doi = "10.1254/fpj.131.341",

language = "English",

volume = "131",

pages = "341--346",

journal = "Folia Pharmacologica Japonica",

issn = "0015-5691",

publisher = "Japanese Pharmacological Society",

number = "5",

}

TY - JOUR

T1 - Novel therapeutic strategy for neurogenesis in the neurodegenerative disorders

AU - Fukunaga, Kohji

AU - Shioda, Norifumi

AU - Morioka, Motohiro

AU - Han, Feng

PY - 2008/7/15

Y1 - 2008/7/15

UR - http://www.scopus.com/inward/record.url?scp=46849087179&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46849087179&partnerID=8YFLogxK

U2 - 10.1254/fpj.131.341

DO - 10.1254/fpj.131.341

M3 - Review article

C2 - 18480563

AN - SCOPUS:46849087179

VL - 131

SP - 341

EP - 346

JO - Folia Pharmacologica Japonica

JF - Folia Pharmacologica Japonica

SN - 0015-5691

IS - 5

ER -